Vasectomy Myth Debunked: NewYork-Presbyterian/Weill Cornell Study Finds Vasectomy Reversal Highly Effective, Even After 15 Years
New York, NY (February 19, 2004) — Debunking a
popular myth about vasectomy, a new study by physician-scientists at NewYork-Presbyterian
Hospital/Weill Cornell Medical Center finds that vasectomy reversal is highly
effective, even 15 years or more after the vas deferens, the tube that carries
sperm, is blocked. The study, published in the January
Journal of Urology,
documents the highest pregnancy rates following vasectomy of any study to date.
Whether a man had a vasectomy this year or 15 years ago, there was no difference
in the pregnancy rate achieved following a vasectomy reversal, with an average
84-percent likelihood of pregnancy over two years, the study finds. (Comparatively,
healthy men without vasectomy can expect a pregnancy rate of 90 percent.) Previous
studies have demonstrated pregnancy rates following vasectomy reversal of only
50-60 percent, a difference that can be attributed to advances in vasectomy-reversal
techniques. The study also finds that at intervals of greater than 15 years,
the pregnancy rate dropped to 44 percent.
"Vasectomy is not a permanent condition. For men who had a vasectomy less
than 15 years ago, a reversal will result in a much higher pregnancy rate than
sperm aspiration and in vitro fertilization (IVF) with intracytoplasmic sperm
injection (ICSI). Even at intervals greater than 15 years, reversal outcomes
will equal or exceed those of IVF with ICSI," says Dr. Marc Goldstein, the
study's lead author, Professor of Reproductive Medicine and Urology at Weill
Cornell Medical College, and Surgeon-in-Chief of Male Reproductive Medicine and
Microsurgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. IVF
with ICSI results in pregnancy rates of up to 50 percent per attempt at the best
centers, and may take two or three tries to achieve one pregnancy.
"Additionally, vasectomy reversal is a more cost-effective option, especially
for couples seeking more than one child," adds Dr. Goldstein. "IVF
with ICSI typically costs approximately two to three times more than vasectomy
reversal. And, unlike IVF with ICSI, a reversal is covered by health insurance
in certain states, including New York."
Men seek to reverse a vasectomy for two main reasons: they either remarried
or they lost a child, says Dr. Goldstein. Approximately half a million vasectomies
are performed each year in the U.S., and it is estimated that between two percent
and six percent of the men will ultimately seek reversal.
The study involved a retrospective analysis of 213 vasectomy reversals performed
at NewYork-Presbyterian Hospital/Weill Cornell Medical Center between 1984
and 2001. Outcomes data were stratified according to obstructive interval:
less-than 5 years, 5-10 years, 10-15 years, and greater than 15
years. Only men with fertile female partners were studied.
The study also found that the level of patency (or lack of obstruction) in
the vas deferens remained high up to 15 years, averaging at 90 percent, and
holding at this rate no matter when the vasectomy was performed. This finding
contradicts other study results; this may be explained by the recent introduction
of improved surgical techniques for vasectomy reversal. One such technique,
the microdot method for precision suture placement, was pioneered by Dr. Goldstein
in 1998.
Another vasectomy myth holds that the presence of granulomas — knots that
form in the vas deferens when a vasectomy is too tight — result in a higher
patency and pregnancy rate. The current study finds that granulomas, which
occurred in 28 percent of vasectomies, did not increase patency to a statistically
significant level and had no impact on pregnancy.
The study represents the first analysis of pregnancy and patency following
two different types of vasectomy reversal — vasovasostomy (VV) and vasoepididymostomy
(VE) — finding that patients who underwent a bilateral VV had a significantly
greater patency rate (95%) than patients who had unilateral VV and VE (83%)
and bilateral VE (83%). However, pregnancy rates were consistent.
Vasovasostomy (VV) involves a reconnection of the vas deferens to the vas deferens.
Vasoepididymostomy (VE) connects the vas deferens to the epididymis, a duct
that carries sperm to the vas deferens. In general, if sperm is present in
the vas fluid, VV is performed. If sperm is not present in the vas fluid, VE
is performed. Both outpatient procedures take less than three hours.
For men unable to achieve pregnancy following VV or VE, the next step is assisted
reproductive techniques such as intra-uterine insemination (IUI) or IVF with
ICSI, says Dr. Goldstein.
The study's co-authors are Dr. Stephen Boorjian, a urology resident at NewYork-Presbyterian
Hospital/Weill Cornell and Michael Lipkin, a medical student.
Recognized as leaders in the field male reproductive surgery, Dr. Goldstein
and his colleagues at the Center for Male Reproductive Medicine and Microsurgery
at NewYork-Presbyterian Hospital/Weill Cornell Medical Center have received
honors for their instructional videos. In 2003, they received the American
Urological Association's "Audio-Visual Award" (first prize) for "Ultra-Precise
Multilayer Microsurgical Vasovasostomy: Tricks of the Trade." And in 2002,
they received the American Society for Reproductive Medicine's "Best Video
Award" for "Three Techniques of Microsurgical Intussusception Vasoepididymostomy:
Cost-Effective Options for Obstructive Azoospermia."
Powered by Big Medium™
Contact Info